Biohaven Pharmaceutical H... (BHVN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
36.22
0.65 (1.83%)
At close: Jan 15, 2025, 1:34 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
PE Ratio | -7.47 | -1.09 | -1.22 | -2.2 | -0.67 | n/a | n/a |
PS Ratio | n/a | n/a | 0.57 | n/a | n/a | n/a | n/a |
PB Ratio | 7.12 | 1.15 | 7.54 | 15.58 | -47.68 | n/a | n/a |
P/FCF Ratio | -9.1 | -1.83 | -1.78 | -3.32 | -0.93 | n/a | n/a |
P/OCF Ratio | -9.19 | -2.09 | -1.79 | -3.44 | -0.94 | n/a | n/a |
OCF/S Ratio | n/a | n/a | -0.32 | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.07 | 0.06 | 18.07 | 15.94 | n/a | 0.78 | n/a |
Quick Ratio | 7.99 | 5.90 | 2.10 | 1.68 | 4.96 | 13.94 | 14.49 |
Current Ratio | 7.98 | 6.52 | 2.26 | 3.00 | 4.96 | 13.94 | 14.49 |
Asset Turnover | n/a | n/a | 3.26 | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | 37.69 | n/a | n/a |
Return on Equity (ROE) | -0.95 | -1.06 | -6.16 | -7.07 | 71.23 | n/a | n/a |
Return on Assets (ROA) | -0.8 | -0.86 | -1.5 | -1.06 | -1.54 | n/a | n/a |
Return on Capital (ROIC) | -0.95 | -0.99 | -2.19 | -1.4 | -1.72 | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 80.18% | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -46.23% | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -45.93% | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -47.33% | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | -31.74% | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -47.03% | n/a | n/a | n/a | n/a |